(lp0
S"Judge puts Seattle Genetics' $2 billion deal with Immunomedics on hold Puget Sound Business Journal  - Mar 9, 2017 17, Immunomedics sued shareholder VenBio for attempting to take over Immunomedics' board and kill the licensing deal with Seattle Genetics. VenBio had a 9.9 percent stake in Immunomedics at the the time of the lawsuit. VenBio says the Seattle Genetics&nbsp;...Seattle Genetics, Inc.  Files An 8-K Other Events - Market ExclusiveImmunomedics' IMMU-132 deal on hold; shares rally 11%; Seattle Genetics down a ... - Seeking Alpha"
p1
aS"Analyst's Indicator Review for SVB Financial Group , Seattle Genetics ... The USA Commerce - 18 hours ago While trading at volume below than average, Seattle Genetics, Inc.  previous 52-week high was $75.36 and moved up 91.41% over the same period, trading at a volume of 539.36 thousand."
p2
aS'Option Market Alert: Seattle Genetics Inc Implied Price Swing Hits An ... CML News - 11 hours ago No Risk Alert Here: Before we dive into any analysis we simply note that Seattle Genetics Inc  risk is neither elevated nor depressed.'
p3
aS"Seattle Genetics  Up 8.2% Since Earnings Report: Can It Continue? Zacks.com - Mar 14, 2017 Seattle Genetics continues to work on expanding Adcetris' label further. The company.Takeda released full data from the ALCANZA phase III study in patients with CD30-expressing cutaneous T-cell lymphoma  in Dec 2016."
p4
aS'Big Banks Continue to be Large Stakeholders in Seattle Genetics, Inc. (NASDAQ ... Midway Monitor - 9 hours ago Based on the lastest quarterly filings, institutions continue to be large stakeholders in Seattle Genetics, Inc. .Ladenburg Thalmann Financial Services Inc. Sells 1205 Shares of Seattle ... - The Cerbat Gem'
p5
aS'Stock Returns: Tesaro Inc  is Beating Seattle Genetics Inc ... CML News - Mar 25, 2017 This is a snapshot to compare the stock returns for Seattle Genetics Inc  versus Tesaro Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months.Seattle Genetics, Inc.  Receives An Update From Brokers - The De Soto Edge'
p6
aS'Seattle Genetics to resume trials as FDA lifts clinical hold Daily Mail - Mar 6, 2017 March 6  - Seattle Genetics Inc said on Monday the U.S. Food and Drug Administration lifted a clinical hold on several early stage studies testing its experimental cancer drug.FDA lifts hold on Seattle Genetics drug trials - ReutersSeattle Genetics : FDA Lifts Hold on Trial of AML Drug - Yahoo Finance'
p7
aS'IMPORTANT SEATTLE GENETICS INC. INVESTOR REMINDER: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 28, 2017 NEW YORK, Feb. 28, 2017  -- Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a class action lawsuit has been filed against Seattle Genetics Inc.   and certain of its&nbsp;...'
p8
aS'Brokerages Set Seattle Genetics, Inc.  PT at $60.46 Chaffey Breeze - Mar 28, 2017 Seattle Genetics logo Shares of Seattle Genetics, Inc.  have been assigned a consensus rating of Hold from the twenty brokerages that are currently covering the firm.Snap  Gets Stifel Nicolaus Civerage with $24.00 Target, Seattle Genetics ... - Wolcott Daily'
p9
aS'Hot Stocks Among Investors: Seattle Genetics, Inc. , RSP Permian, Inc ... Post Analyst - 16 hours ago Seattle Genetics, Inc.  has made its way to a 12-month gain of 91.41%. Turning to RSP Permian, Inc. , its shares were trading at $38.92 a gain of $0.27, on the trading floor.'
p10
a.